TransMedics Group Management
Management criteria checks 3/4
TransMedics Group's CEO is Waleed Hassanein, appointed in Aug 1998, has a tenure of 25.75 years. total yearly compensation is $6.76M, comprised of 9.4% salary and 90.6% bonuses, including company stock and options. directly owns 1.43% of the company’s shares, worth $60.44M. The average tenure of the management team and the board of directors is 5.1 years and 10.8 years respectively.
Key information
Waleed Hassanein
Chief executive officer
US$6.8m
Total compensation
| CEO salary percentage | 9.4% |
| CEO tenure | 25.8yrs |
| CEO ownership | 1.4% |
| Management average tenure | 5.1yrs |
| Board average tenure | 10.8yrs |
Recent management updates
Recent updates
TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
May 06TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 24
TransMedics Group: Founder Led Company With Solid Potential
Apr 19Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
Mar 19TransMedics Group: Huge Opportunity In Organ Transplants
Mar 12TransMedics: A Very Expensive Growth Stock
Feb 07With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For
Jan 23Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Jan 02Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year
Aug 06TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing
Jun 29Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts
May 06Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Apr 09Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Jan 16TransMedics: Game Changer Technology Will Boost Revenue Growth
Oct 20TransMedics Is A Buy Following Q2 FY22 Earnings Upside
Aug 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | US$7m | US$634k | -US$25m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$18m |
| Mar 31 2023 | n/a | n/a | -US$28m |
| Dec 31 2022 | US$3m | US$575k | -US$36m |
| Sep 30 2022 | n/a | n/a | -US$42m |
| Jun 30 2022 | n/a | n/a | -US$48m |
| Mar 31 2022 | n/a | n/a | -US$47m |
| Dec 31 2021 | US$7m | US$535k | -US$44m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$30m |
| Mar 31 2021 | n/a | n/a | -US$28m |
| Dec 31 2020 | US$2m | US$534k | -US$29m |
| Sep 30 2020 | n/a | n/a | -US$32m |
| Jun 30 2020 | n/a | n/a | -US$35m |
| Mar 31 2020 | n/a | n/a | -US$36m |
| Dec 28 2019 | US$3m | US$449k | -US$34m |
| Sep 28 2019 | n/a | n/a | -US$32m |
| Jun 29 2019 | n/a | n/a | -US$29m |
| Mar 30 2019 | n/a | n/a | -US$26m |
| Dec 29 2018 | US$524k | US$384k | -US$24m |
| Sep 29 2018 | n/a | n/a | -US$21m |
| Jun 30 2018 | n/a | n/a | -US$20m |
| Mar 31 2018 | n/a | n/a | -US$20m |
| Dec 30 2017 | US$601k | US$351k | -US$21m |
Compensation vs Market: Waleed's total compensation ($USD6.76M) is about average for companies of similar size in the US market ($USD6.72M).
Compensation vs Earnings: Waleed's compensation has increased whilst the company is unprofitable.
CEO
Waleed Hassanein (55 yo)
25.8yrs
Tenure
US$6,758,070
Compensation
Dr. Waleed H. Hassanein, M.D. is the Founder of Transmedics Group, Inc. and has been its President, Chief Executive Officer and Director since August 1998. He Founded TransMedics, Inc. in August 1998 and h...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 25.8yrs | US$6.76m | 1.43% $ 60.4m | |
| CFO, Treasurer & Secretary | 9.2yrs | US$2.64m | 0.071% $ 3.0m | |
| Senior Vice President of Supply Chain & Operations | 1.3yrs | US$2.52m | 0.0098% $ 414.8k | |
| Senior VP | less than a year | US$2.35m | no data | |
| Chief Commercial Officer | 18.3yrs | US$2.63m | 0.063% $ 2.7m | |
| Senior Director of Technology Development | 5.3yrs | no data | no data | |
| Vice President of Human Resources | 3.2yrs | no data | no data | |
| Vice President of Global Regulatory Affairs | 4.9yrs | US$813.47k | 0% $ 0 |
5.1yrs
Average Tenure
55yo
Average Age
Experienced Management: TMDX's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 25.8yrs | US$6.76m | 1.43% $ 60.4m | |
| Independent Director | 21.3yrs | US$220.28k | 0.92% $ 39.0m | |
| Independent Director | 3.3yrs | US$238.62k | 0% $ 0 | |
| Independent Chairman | 13.3yrs | US$262.32k | 0.59% $ 24.9m | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | 8.3yrs | US$232.26k | 0% $ 0 | |
| Independent Director | 7.8yrs | US$237.74k | 0% $ 0 |
10.8yrs
Average Tenure
69yo
Average Age
Experienced Board: TMDX's board of directors are seasoned and experienced ( 10.8 years average tenure).